Pathogen-associated lung injury

Clinical trials for Pathogen-associated lung injury explained in plain language.

Never miss a new study

Get alerted when new Pathogen-associated lung injury trials appear

Sign up with your email to follow new studies for Pathogen-associated lung injury, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a pill help patients breathe easier with ARDS?

Disease control Recruiting now

This study tests a drug called vadadustat in 1,100 hospitalized adults with acute respiratory distress syndrome (ARDS) caused by infection. Participants take either a low or high dose of vadadustat or a placebo daily for up to 14 days. The goal is to see if the drug reduces death…

Matched conditions: PATHOGEN-ASSOCIATED LUNG INJURY

Phase 2/3 • Sponsor: Paul Potnuru • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

Pathogen-associated lung injury

Get alerted when new Pathogen-associated lung injury trials appear

Could a pill help patients breathe easier with ARDS?